N. Alon
Novartis (United States)(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Pneumonia and Respiratory Infections, Antibiotic Resistance in Bacteria, Pain Mechanisms and Treatments, Neonatal Respiratory Health Research
Most-Cited Works
- → Lamotrigine in the treatment of painful diabetic neuropathy(1998)73 cited
- → (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: A Wingless β-Catenin Agonist That Increases Bone Formation Rate(2009)52 cited
- → Eradication of early P. aeruginosa infection in children <7 years of age with cystic fibrosis: The early study(2018)41 cited
- → alpha-L-Fucosidase is quantitatively reduced in cultured lymphoblasts from patients with cystic fibrosis.(1981)12 cited
- → WS01.2 TOBI ® for eradication of early P. aeruginosa infection in paediatric cystic fibrosis patients: the EARLY study(2016)1 cited
- WS01.3 A a€ surprisinga€TM pair: the synergistic antimicrobial activity of polymyxin B in combination with the cystic fibrosis drug ivacaftor against polymyxin-resistant P. aeruginosa(2016)